Form 8.3 - WILLIS TOWERS WATSON PLC - Amendment

LONDON--()-- 

Ap19

FORM 8.3 - Amendment to purchase

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 30 April 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)

(1)

Relevant securities

1,704,431

1.32%

165,987

0.13%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

72,359

0.06%

0

0.00%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

6,100

0.00%

6,100

0.00%

 

 

 

 

TOTAL:

 

 

 

 

1,782,890

1.38%

172,087

0.13%

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit

Purchase

2

263.1350 USD

Purchase

2

262.0535 USD

Purchase

5

261.1600 USD

Purchase

9

261.5244 USD

Purchase

23

259.3600 USD

Purchase

32

247.6700 USD

Purchase

50

259.2700 USD

Purchase

79

260.9700 USD

Purchase

88

260.8800 USD

Purchase

100

257.2400 USD

Purchase

100

256.6250 USD

Purchase

100

260.5500 USD

Purchase

200

263.0300 USD

Purchase

300

260.6533 USD

Purchase

350

260.4874 USD

Purchase

458

261.4372 USD

Purchase

502

260.5528 USD

Purchase

577

260.4057 USD

Purchase

586

259.2985 USD

Purchase

1,331

262.2107 USD

Purchase

1,435

259.6717 USD

Purchase

1,457

261.1630 USD

Purchase

1,924

259.9086 USD

Purchase

3,919

258.8600 USD

Purchase

5,866

259.9134 USD

Purchase

7,581

260.5190 USD

Purchase

8,618

261.1849 USD

Purchase

11,523

260.5046 USD

Purchase

15,064

260.6826 USD

Purchase

15,809

258.8240 USD

Purchase

51,176

260.6910 USD

Sale

2

263.1350 USD

Sale

4

262.0535 USD

Sale

6

259.6900 USD

Sale

10

261.2192 USD

Sale

10

259.3440 USD

Sale

12

259.0150 USD

Sale

12

259.4475 USD

Sale

18

259.2250 USD

Sale

18

259.2733 USD

Sale

18

259.2433 USD

Sale

20

260.4460 USD

Sale

24

259.4662 USD

Sale

24

259.5900 USD

Sale

30

259.3290 USD

Sale

32

247.6700 USD

Sale

36

259.1983 USD

Sale

50

259.2700 USD

Sale

67

259.2937 USD

Sale

88

260.8800 USD

Sale

100

259.9800 USD

Sale

100

260.9300 USD

Sale

100

259.9600 USD

Sale

100

260.5100 USD

Sale

112

259.2412 USD

Sale

154

260.2603 USD

Sale

184

261.0193 USD

Sale

484

260.4946 USD

Sale

640

260.5325 USD

Sale

1,000

260.5468 USD

Sale

1,037

257.6754 USD

Sale

1,405

259.4726 USD

Sale

1,870

260.5782 USD

Sale

1,984

260.9141 USD

Sale

2,987

260.8073 USD

Sale

3,100

259.3043 USD

Sale

3,427

260.9893 USD

Sale

3,652

260.9759 USD

Sale

3,765

259.3862 USD

Sale

3,817

258.8600 USD

Sale

4,098

260.5722 USD

Sale

4,125

260.6380 USD

Sale

6,176

260.7571 USD

Sale

6,263

260.3581 USD

Sale

6,884

260.5879 USD

Sale

9,179

260.6731 USD

Sale

9,630

258.0454 USD

Sale

11,384

260.8187 USD

Sale

19,926

260.7073 USD

Sale

21,000

260.9159 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure:

5 May 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates

Put Options

Purchased

-100

220.0000

American

Jul 16, 2021

Call Options

Purchased

100

240.0000

American

Jul 16, 2021

Call Options

Purchased

6,000

220.0000

American

Jul 16, 2021

Put Options

Purchased

-6,000

200.0000

American

Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

Category Code: RET
Sequence Number: 736651
Time of Receipt (offset from UTC): 20210505T135538+0100

Contacts

BARCLAYS PLC

Contacts

BARCLAYS PLC